Overview

A Study of the Pharmacokinetics of Ustekinumab in Chinese Male Subjects

Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
A study of the pharmacokinetics of ustekinumab in Chinese male subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Centocor, Inc.
Treatments:
Ustekinumab